Skip to Main Content

Paper Details

Outcomes in liver transplant recipients with nonalcoholic fatty liver disease-related HCC: results from the US multicenter HCC transplant consortium.
Liver Transpl
1
2023
-lymphocyte, HCC, HCCs, NAFLD, Patients, alpha fetoprotein, diabetes, lymphocyte, neutrophil, nonalcoholic fatty liver disease, patients, tumor
Author NameAffiliation
Daniela MarkovicDavid Geffen School of Medicine at university of california los angeles
Thomas M FishbeinMedstar Georgetown Transplant Institute, Georgetown University
Vatche G AgopianDumont-university of california los angeles (University of California, Los Angeles) Transplant and Liver Cancer Centers, David Geffen School of Medicine at university of california los angeles
  • 1 - 3

Datasets

Release 1.2